Beyond Tsetse - Implications for Research and Control of Human African Trypanosomiasis Epidemics

Trends in Parasitology

Volumn 32, Issue 3, 2016, Pages 230-241

  Welburn, Susan C ^a   Molyneux, David H ^b   Maudlin, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Epidemics; Epigenetics; Famine; HAT; Sleeping sickness; Tsetse

Indexed keywords

PENTAMIDINE;

AFRICA SOUTH OF THE SAHARA; AFRICAN TRYPANOSOMIASIS; CHEMOPROPHYLAXIS; EPIDEMIC; ETHNIC GROUP; FOUNDER EFFECT; GAMBIA; GENETIC SELECTION; GENETIC VARIABILITY; GLOSSINA; GLOSSINIDAE; HUMAN; INFECTION SENSITIVITY; NONHUMAN; PARASITE CONTROL; PARASITE PREVALENCE; PARASITE TRANSMISSION; PARASITE VECTOR; POLYMERASE CHAIN REACTION; PROTIST LIFE CYCLE STAGE; RESEARCH; REVIEW; SALIVARY GLAND; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE; VECTOR CONTROL; VERTICAL TRANSMISSION; ANIMAL; DISEASE OUTBREAKS; PARASITOLOGY; TRANSMISSION; TRENDS; TRYPANOSOMIASIS, AFRICAN;

AFRICA SOUTH OF THE SAHARA; ANIMALS; DISEASE OUTBREAKS; HUMANS; RESEARCH; TRYPANOSOMIASIS, AFRICAN; TSETSE FLIES;

EID: 84960081288     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.11.008     Document Type: Review

References (99)

1. Checchi F., et al. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect. Dis. 2008, 8:16.
2. Odiit M., et al. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda. East Afr. Med. J. 1997, 74:792-795.
3. Simarro P.P., et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl. Trop. Dis. 2012, 6:e1859.
4. Welburn S.C., et al. Sleeping sickness: a tale of two diseases. Trends Parasitol. 2001, 17:19-24.
5. Franco J.R., et al. Epidemiology of human African trypanosomiasis. Clin. Epidemiol. 2014, 6:257-275.
6. Simarro P.P., et al. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl. Trop. Dis. 2011, 5:e1007.
7. Simarro P.P., et al. Risk for human African trypanosomiasis, Central Africa, 2000-2009. Emerg. Infect. Dis. 2011, 17:2322-2324.
8. Simarro P.P., et al. Monitoring the progress towards the elimination of Gambiense human African trypanosomiasis. PLoS Negl. Trop. Dis. 2015, 9:e0003785.
9. Rock K.S., et al. Mathematical models of human African trypanosomiasis epidemiology. Mathematical Models for Neglected Tropical Diseases: Essential Tools for Control and Elimination, Part A 2015, 53-133. Elsevier. R. Anderson, M.G. Basáñez (Eds.).
10. Simarro P.P., et al. The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int. J. Health. Geogr. 2010, 9:57.
11. Wardrop N., et al. Bayesian geostatistical analysis and prediction of Rhodesian human African trypanosomiasis. PLoS Negl. Trop. Dis. 2010, 4:e914.
12. Courtin F., et al. Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past. Trop. Med. Int. Health 2008, 13:334-344.
13. Krafsur E.S. Tsetse flies: genetics, evolution, and role as vectors. Infect. Genet. Evol. 2009, 9:124-141.
14. Weetman D., Clarkson C.S. Evolving the world's most dangerous animal. Trends Parasitol. 2015, 31:39-40.
15. Hide G., et al. Epidemiological relationships of Trypanosoma brucei stocks from southeast Uganda: evidence for different population structures in human infective and non-human infective isolates. Parasitology 1994, 109:95-111.
16. Maudlin I., et al. Extrachromosomal inheritance of susceptibility to trypanosome infection in tsetse flies. II. Susceptibility of selected lines of Glossina morsitans morsitans to different stocks and species of trypanosome. Ann. Trop. Med. Parasitol. 1986, 80:97-105.
17. Janelle J., et al. Monitoring the pleomorphism of Trypanosoma brucei gambiense isolates in mouse: impact on its transmissibility to Glossina palpalis gambiensis. Infect. Genet. Evol. 2009, 9:1260-1264.
18. Ravel S., et al. Cyclical transmission of Trypanosoma brucei gambiense in Glossina palpalis gambiensis displays great differences among field isolates. Acta Trop. 2006, 100:151-155.
19. Duke H.L. On the transmissibility by Glossina of Trypanosoma brucei, T. rhodesiense and T. gambiense with special reference to old laboratory strains. Parasitology 1934, 26:153-162.
20. Van Hoof L.M.J.J. Observations on trypanosomiasis in the Belgian Congo. Trans. R. Soc. Trop. Med. Hyg. 1947, 40:727-761.
21. Jordan A.M. Trypanosome infection rates in Glossina morsitans submorsitans Newst. in Northern Nigeria. Bull. Entomol. Res. 1964, 55:219-231.
22. Balmer O., et al. Phylogeography and taxonomy of Trypanosoma brucei. PLoS Negl. Trop. Dis. 2011, 5:e961.
23. Jamonneau V., et al. Mixed infections of trypanosomes in tsetse and pigs and their epidemiological significance in a sleeping sickness focus of Côte d'Ivoire. Parasitology 2004, 129:693-702.
24. Farikou O., et al. Tsetse fly blood meal modification and trypanosome identification in two sleeping sickness foci in the forest of southern Cameroon. Acta Trop. 2010, 116:81-88.
25. Truc P., et al. Epidemiological aspects of the transmission of the parasites causing human African trypanosomiasis in Angola. Ann. Trop. Med. Parasitol. 2011, 105:261-265.
26. Kagbadouno M.S., et al. Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes?. PLoS Negl. Trop. Dis. 2012, 6:e1949.
27. Tongué K.L., et al. Is there a suburban sleeping sickness in Libreville?. Afr. Health Sci. 2013, 13:266-269.
28. Koffi M., et al. Population genetics and reproductive strategies of African trypanosomes: revisiting available published data. PLoS Negl. Trop. Dis. 2015, 9:e0003985.
29. Bruce D., et al. Further report on sleeping sickness in Uganda. Rep. Sleep Sickness Comm. R. Soc. 1903, 4:1-87.
30. Dutton J.E. Note on a Trypanosoma occurring in the blood of man. BMJ 1902, ii:881-884.
31. Fèvre E.M., et al. Reanalyzing the 1900-1920 sleeping sickness epidemic in Uganda. Emerg. Infect. Dis. 2004, 10:567-573.
32. Simarro P.P., et al. Eliminating human African trypanosomiasis: where do we stand and what comes next?. PLoS Negl. Trop. Dis. 2008, 5:e55.
33. Duggan A.J. A survey of sleeping sickness in Northern Nigeria from the earliest times to the present day. Trans. R. Soc. Trop. Med. Hyg. 1962, 56:439-480.
34. Ford J. The Role of the Trypanosomiases in African Ecology: A Study of the Tsetse Fly Problem 1971, Clarendon Press.
35. Kaba D., et al. L'impact de la guerre sur l'evolution de la THA dans le centre-ouest de la Cote d'Ivoire. Trop. Med. Int. Health 2006, 11:136-143.
36. Berrang Ford L. Civil conflict and sleeping sickness in Africa in general and Uganda in particular. Confl. Health 2007, 1:6.
37. Berrang-Ford L., et al. Conflict and human African trypanosomiasis. Soc. Sci. Med. 2011, 72:398-407.
38. Moore A., Richer M. Re-emergence of epidemic sleeping sickness in southern Sudan. Trop. Med. Int. Health 2001, 6:342-347.
39. Koerner T., et al. The 1901 Uganda sleeping sickness epidemic revisited - a case of mistaken identity?. Parasit. Today 1995, 11:303-306.
40. Funk S., et al. Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining Gambiense human African trypanosomiasis. PLoS Comput. Biol. 2013, 9:e1002855.
41. Jamonneau V., et al. Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl. Trop. Dis. 2012, 6:e1691.
42. McLetchie J.L. The control of sleeping sickness in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 1948, 41:445-480.
43. Morris K.R.S. Planning the control of sleeping sickness. Trans. R. Soc. Trop. Med. Hyg. 1949, 43:165-198.
44. Picozzi K., et al. Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 2005, 331:1238-1241.
45. Bucheton B., et al. Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol. 2011, 33:438-447.
46. Courtin D., et al. HLA-G 3' UTR-2 haplotype is associated with human African trypanosomiasis susceptibility. Infect. Genet. Evol. 2013, 17:1-7.
47. Cooke G.S., Hill A.V.S. Genetics of susceptibility to human infectious diseases. Nat. Rev. Genet. 2001, 2:967-977.
48. Tibayrenc M. Human genetic diversity and the epidemiology of parasitic and other transmissible diseases. Adv. Parasitol. 2007, 64:377-422.
49. Kaboré J., et al. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients. Infect. Genet. Evol. 2011, 11:1250-1255.
50. Wastling S.L., et al. Latent Trypanosoma brucei gambiense foci in Uganda: a silent epidemic in children and adults?. Parasitology 2011, 138:1480-1487.
51. Koffi M., et al. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:209-214.
52. Malvy D., Chappuis F. Sleeping sickness. Clin. Microbiol. Infect. 2011, 17:986-995.
53. Sudarshi D., et al. Human African trypanosomiasis presenting at least 29 years after infection - what can this teach us about the pathogenesis and control of this neglected tropical disease?. PLoS Negl. Trop. Dis. 2014, 8:e3349.
54. Stoppini L., et al. Infection of organotypic slice cultures from rat central nervous tissue with Trypanosoma brucei brucei. Int. J. Med. Microbiol. 2000, 290:105-113.
55. Blum J.A., et al. Human African trypanosomiasis in endemic populations and travellers. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:905-913.
56. Neuberger A., et al. The changing epidemiology of human African trypanosomiasis among patients from nonendemic countries - 1902-2012. PLoS ONE 2014, 9:e88647.
57. Rocha G., et al. Possible cases of sexual and congenital transmission of sleeping sickness. Lancet 2004, 363:247.
58. MacLean L., et al. Severity of human African trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect. Immun. 2004, 72:7040-7044.
59. Capewell P., et al. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome. Parasitology 2015, 142(Suppl. 1):S108-S119.
60. Courtin D., et al. Host genetics in African trypanosomiasis. Infect. Genet. Evol. 2008, 8:229-238.
61. Uzureau P., et al. Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature 2013, 501:430-434.
62. Genovese G., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329:841-845.
63. Shanahan T.M., et al. Atlantic forcing of persistent drought in West Africa. Science 2009, 324:377-380.
64. Devereux S. Famine in the Twentieth Century. IDS Working Paper 105 2000, Institute of Developmental Studies.
65. Christy C. Sleeping sickness. J. R. Afr. Soc. 1903, 3:1-11.
66. Lyons M. From 'Death Camps' to cordon sanitaire: the development of sleeping sickness policy in the Uele District of the Belgian Congo, 1903-1914. J. Afr. Hist. 1985, 26:69-91.
67. Collin S., et al. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin. Infect. Dis. 2004, 38:612-619.
68. Currie T.E., et al. Cultural phylogeography of the Bantu languages of sub-Saharan Africa. Proc. Biol. Sci. 2013, 280:20130695.
69. Rexová K., et al. Cladistic analysis of Bantu languages: a new tree based on combined lexical and grammatical data. Naturwissenschaften 2006, 93:189-194.
70. De Filippo C., et al. Y-Chromosomal variation in sub-Saharan Africa: insights into the history of Niger-Congo groups. Mol. Biol. Evol. 2011, 28:1255-1269.
71. Ansari Pour N., et al. Evidence from Y-chromosome analysis for a late exclusively eastern expansion of the Bantu-speaking people. Eur. J. Hum. Genet. 2013, 21:423-429.
72. Wengert O., et al. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings. Parasitol. Int. 2014, 63:557-560.
73. Lindner A.K., Priotto G. The unknown risk of vertical transmission in sleeping sickness - a literature review. PLoS Negl. Trop. Dis. 2010, 4:e783.
74. Eperon G., et al. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop. 2007, 101:31-39.
75. Woodruff A.W., et al. A 'healthy' carrier of African trypanosomiasis. J. Infect. 1982, 5:89-92.
76. Ruiz-Postigo J.A., et al. Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?. PLoS Negl. Trop. Dis. 2012, 6:e1541.
77. Lyons M. The Colonial Disease: A Social History of Sleeping Sickness in Northern Zaire 1900-1940 2002, Cambridge University Press.
78. Heijmans B.T., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:17046-17049.
79. Jang H., Serra C. Nutrition, epigenetics, and diseases. Clin. Nutr. Res. 2014, 3:1-8.
80. Painter R.C., et al. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 2008, 115:1243-1249.
81. Painter R.C., et al. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am. J. Clin. Nutr. 2006, 84:322-327.
82. Roseboom T., et al. The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 2006, 82:485-491.
83. Paquet C., et al. Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991). Bull. Soc. Pathol. Exot. 1995, 88:38-41.
84. van Nieuwenhove S. Gambiense sleeping sickness: re-emerging and soon untreatable?. Bull. World Health Org. 2000, 78:1283.
85. Stanghellini A., Josenando T. The situation of sleeping sickness in Angola: a calamity. Trop. Med. Int. Health 2001, 6:330-334.
86. Stanghellini A. Prophylactic strategies in human African trypanosomiasis. Progress in Human African Trypanosomiasis, Sleeping Sickness 1999, 301-313. Springer Verlag. M. Dumas (Ed.).
87. Simarro P.P., et al. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea. Trop. Med. Int. Health 2006, 11:36-46.
88. Welburn S.C., et al. Crisis, what crisis? Control of Rhodesian sleeping sickness. Trends Parasitol. 2006, 22:123-128.
89. Kgori P.M., et al. The use of aerial spraying to eliminate tsetse from the Okavango Delta of Botswana. Acta Trop. 2006, 99:184-199.
90. Fèvre E.M., et al. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. Lancet 2001, 358:625-628.
91. Batchelor N.A., et al. Spatial predictions of Rhodesian human African trypanosomiasis (sleeping sickness) prevalence in Kaberamaido and Dokolo, two newly affected districts of Uganda. PLoS Negl. Trop. Dis. 2009, 3:e563.
92. Simarro P.P., et al. Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination. Res. Rep. Trop. Med. 2013, 4:1-6.
93. Torr S.J., et al. Less is more: restricted application of insecticide to cattle to improve the cost and efficacy of tsetse control. Med. Vet. Entomol. 2007, 21:53-64.
94. Muhanguzi D., et al. Improvements on restricted insecticide application protocol for control of human and animal African trypanosomiasis in eastern Uganda. PLoS Negl. Trop. Dis. 2014, 8:e3284.
95. McConnell T. Rival armies battle over town shattered by South Sudan war. The Times 2014, 30 September.
96. Lejon V., et al. Elimination of sleeping sickness hindered by difficult diagnosis. Bull. World Health Organ. 2013, 91:718.
97. Watson-Jones D., et al. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop. Med. Int. Health 2005, 10:934-943.
98. Derda R., et al. Enabling the development and deployment of next generation point-of-care diagnostics. PLoS Negl. Trop. Dis. 2015, 9:e0003676.
99. Deborggraeve S., Büscher P. Molecular diagnostics for sleeping sickness: what is the benefit for the patient?. Lancet Infect. Dis. 2010, 10:433-439.